CSID Genetics Overview

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare carbohydrate malabsorption disorder that produces chronic diarrhea, abdominal pain, gas, distention, and bloating in patients who have a sucrase-isomaltase enzyme deficiency. The sucrase-isomaltase enzyme is necessary for digesting dietary sucrose and starch for absorption in the small intestine.

The genetic etiology of CSID is well established. In a 2012 study of 31 biopsy-confirmed CSID patients, the most common genotypes were compound heterozygous (74.2%), simple heterozygous (19.4%) and homozygous (6.5%).1 There are 36 identified single nucleotide polymorphisms (SNPs), nonsense mutations (inserted stop codon) and deletions in the SI gene described in the literature that have been associated with CSID.1-9 Single nucleotide polymorphisms result in single amino acid changes in the sucrase-isomaltase glycoprotein, which manifests with a variety of biochemical phenotypes, ranging from a lack of enzyme activity due to improper folding of the protein, to transport defects.6 In addition, there are seven described phenotypic expressions of SI pathogenic variants, and a spectrum of CSID symptom severity.6

An SI gene mutation may, but does not always, lead to a reduction of SI expression or function. Therefore, the manifestation of clinical phenotypes and symptom severity varies.1 The contributing factors are not well known and are possibly related to environmental factors such as overall intestinal health, gastrointestinal infections and diet, especially the amount of sugar and starch consumed.

The SI gene is located on the long arm (q) of chromosome 3 at position 26.1.10

diagram of SI gene

Credit: Genome Decoration Page/NCBI

Figure 1: Location of the SI gene on chromosome 3 at position 26.1.10

Congenital Sucrase-Isomaltase Deficiency was first reported in the 1960s as an autosomal recessive disorder.8 More recent investigations have identified a range of inheritance patterns – SI homozygotes, heterozygotes, and compound heterozygotes. Heterozygous inheritance is the most common pathogenic genotype, and there are multiple clinical case reports of symptomatic carriers with simple heterozygous mutations (single mutation in one allele).1,11 In one genetic study of  25 probands diagnosed with CSID, 2 were homozygous and 23 were compound heterozygous for a CSID genotype.12

Practice Tip

If a pediatric patient is diagnosed with CSID, related symptomatic siblings and one or both parents may also benefit from diagnostic tests for possible CSID.

Practice Tip

Genetic testing for pathogenic SI variants is available, but the genetic test only screens for known variants. If a patient has rare variants that have not yet been investigated for potential pathogenicity, these will not be identified in a genetic test. Therefore, genetic testing is at risk of false negatives.

References

  1. Uhrich S, Wu Z, Huang JY, Scott CR. Four mutations in the SI gene are responsible for the majority of clinical symptoms of CSID. J Pediatr Gastroenterol Nutr. 2012;55(suppl 2):S34-S35.
  2. Alfalah M, Keiser M, Leeb T, et al. Compound heterozygous mutations affect protein folding and function in patients with Congenital Sucrase-Isomaltase Deficiency. Gastroenterology. 2009;136(3):883-92.
  3. Gericke B, Amiri M, Naim HY. The multiple roles of sucrase-isomaltase in the intestinal physiology. Mol Cell Pediatr. 2016;3(1):2. doi: 10.1186/s40348-016-0033-y.
  4. Jacob R, Zimmer KP, Schmitz J, et al. Congenital Sucrase-Isomaltase Deficiency arising from cleavage and secretion of a mutant form of the enzyme. J Clin Invest. 2000;106(2):281-7.
  5. Keiser M, Alfalah M, Pröpsting MJ, et al. Altered folding, turnover, and polarized sorting act in concert to define a novel pathomechanism of Congenital Sucrase-Isomaltase Deficiency. J Biol Chem. 2006;281(20):14393-9.
  6. Naim HY, Heine M, Zimmer KP. Congenital Sucrase-Isomaltase Deficiency: heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex. J Pediatr Gastroenterol Nutr. 2012;55(suppl 2):S13-20.
  7. Ritz V, Alfalah M, Zimmer KP, et al. Congenital Sucrase-Isomaltase Deficiency because of an accumulation of the mutant enzyme in the endoplasmic reticulum. Gastroenterology. 2003;125(6):1678-85.
  8. Sander P, Alfalah M, Keiser M, et al. Novel mutations in the human sucrase-isomaltase gene (SI) that cause congenital carbohydrate malabsorption. Human Mutat. 2006;27(1):119. doi: 10.1002/humu.9392.
  9. Spodsberg N, Jacob R, Alfalah M, et al. Molecular basis of aberrant apical protein transport in an intestinal enzyme disorder. J Biol Chem. 2001;276(26):23506-10.
  10. Genetics Home Reference. SI gene. https://ghr.nlm.nih.gov/gene/SI#location. Last updated June 12, 2018.
  11. Cohen SA. The clinical consequences of sucrase-isomaltase deficiency. Mol Cell Pediatr. 2016;3:5. doi: 10.1186/s40348-015-0028-0.
  12. QOL Medical, LLC. Data on file.